Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide

BACKGROUND: Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the auto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EJNMMI Res
Egile Nagusiak: Anand, Aseem, Morris, Michael J., Larson, Steven M., Minarik, David, Josefsson, Andreas, Helgstrand, John T., Oturai, Peter S., Edenbrandt, Lars, Røder, Martin Andreas, Bjartell, Anders
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785173/
https://ncbi.nlm.nih.gov/pubmed/26960325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-016-0173-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak